Immunopotentiators in Modern Vaccines

7-9 May 2014, Sao Rafael Atlantic Hotel, Albufeira, Algarve, Portugal

  • Increase font size
  • Default font size
  • Decrease font size

Participation

Abstract Submissions

The IMV 2014 Scientific Advisory Panel require authors to submit a one page abstract for each paper they wish to be considered for inclusion in the oral and/or poster programs during IMV 2014. The one page abstract should contain sufficient information for the committee to be able to make a valid decision as to the intrinsic merit of the paper and its relevance to the aims of the conference. Authors should indicate on the reply form whether they prefer oral or poster presentation and which session their abstract is intended for (from the topics outlined within the introduction). Proposals are also invited for panel discussions and special workshops – these special sessions may be scheduled during the daytime conference timetable or alternatively can be allocated as either breakfast or evening sessions.

Abstract proposals should be sent for the attention of John Herriot at Meetings Management (IMV 2014 Conference Organisers). Authors should send their abstract(s) using the Call for Participation Reply Form or by e-mail to John Herriot (please attach abstracts as Word documents).

Closing date for submissions intended for oral presentation: Friday 6th December 2013. Authors will be informed of the status of their contribution(s) in January 2014. Closing date for submissions intended for poster presentation: Friday 28th March 2014.

There will be a Special Poster Session at IMV 2014 as outlined within the introduction.

Publication

Abstracts of all papers to be presented (oral and poster) will be included in a CD ROM which will be distributed to delegates on registration.

Participation

All non-invited speakers will be expected to register as delegates to IMV 2014. Registration will require speakers to pay a registration fee to attend the conference. Travel and accommodation expenses are the responsibility of each non-invited speaker and no direct compensation is awarded for speakers at IMV 2014. Your submission of an abstract testifies to the fact that you will accept these financial conditions.

 

IMV 2014 Delegates

Login details will be supplied after you have registered for the event.


IMV 2014 Sponsors

  • NatureGeneTherapy
  • Immune Design
  • Eurocine Vaccines
  • Mucosis
  • Abivax
  • Inovio Pharmaceuticals
  • European Adjuvant Advisory Committee
  • Univac
  • Seppic
  • Sanofi Pasteur
  • Dynavax Technologies
  • Pfizer
  • Viscogel
  • Infectious Disease Research Institute
  • DNAvaccine.com
  • Aldevron
  • Novartis Vaccines
  • Brenntag

IMV 2014 Downloads

IMV 2014 Leaflet

IMV 2014 Mailing List

Name
E-mail Address
What is 2+6-2?